CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer
SUZHOU, China, March 24, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission of a Type II variation application to the...
Strider Named to Fast Company's 2025 List of Most Innovative Companies
Strategic intelligence firm ranked in the top ten for most innovative security company TOKYO, March 24, 2025 /PRNewswire/ -- Strider Technologies, Inc., the leading provider of strategic intelligence, has been named to Fast Company's prestigious...
Asia's First Single Stock Leveraged & Inverse Products to Debut on HKEX
HONG KONG, March 24, 2025 /PRNewswire/ -- CSOP Asset Management Limited (CSOP), the largest Leveraged & Inverse Products (L&I products) issuer in Hong Kong, is proud to announce the listing of Asia's first batch of 9 single stock L&I...
Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian Cancer
SAN FRANCISCO and SUZHOU, China, March 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...
AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates
HONG KONG, March 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA shingles vaccine has recently received clinical trial...
Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019
-- U.S. IND clearance and revaccination trial initiation supports the differentiated global opportunity for Clover's RSV PreF vaccine (SCB-1019) utilizing validated Trimer-Tag platform -- -- Evaluation of SCB-1019 as part of a respiratory...
Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14
EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical development. Preclinical highlights： EVM14 induced a...
CROSSFIRE REBRANDS TO JENSEN HUGHES, EXPANDING ITS FIRE SAFETY AND PERFORMANCE-BASED DESIGN ENGINEERING OFFERINGS
AUCKLAND, New Zealand, March 24, 2025 /PRNewswire/ -- Jensen Hughes, a global leader in safety, security and risk-based engineering and consulting, today announced that its partner firm, Crossfire, has officially rebranded to Jensen Hughes. This...